DE60044350D1 - Prostata-spezifisches gen pcgem1 und methoden zu dessen verwendung zur erkennung, behandlung und prävention von prostatakrebs - Google Patents
Prostata-spezifisches gen pcgem1 und methoden zu dessen verwendung zur erkennung, behandlung und prävention von prostatakrebsInfo
- Publication number
- DE60044350D1 DE60044350D1 DE60044350T DE60044350T DE60044350D1 DE 60044350 D1 DE60044350 D1 DE 60044350D1 DE 60044350 T DE60044350 T DE 60044350T DE 60044350 T DE60044350 T DE 60044350T DE 60044350 D1 DE60044350 D1 DE 60044350D1
- Authority
- DE
- Germany
- Prior art keywords
- prostate
- prostate cancer
- pcgem1
- recognition
- prevention
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US12646999P | 1999-03-26 | 1999-03-26 | |
PCT/US2000/007906 WO2000058470A1 (en) | 1999-03-26 | 2000-03-24 | Prostate-specific gene, pcgem1, and methods of using pcgem1 to detect, treat, and prevent prostate cancer |
Publications (1)
Publication Number | Publication Date |
---|---|
DE60044350D1 true DE60044350D1 (de) | 2010-06-17 |
Family
ID=22425000
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE60044350T Expired - Lifetime DE60044350D1 (de) | 1999-03-26 | 2000-03-24 | Prostata-spezifisches gen pcgem1 und methoden zu dessen verwendung zur erkennung, behandlung und prävention von prostatakrebs |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP1185639B1 (de) |
JP (1) | JP4942248B2 (de) |
AT (1) | ATE466938T1 (de) |
AU (1) | AU778088B2 (de) |
CA (1) | CA2368385C (de) |
DE (1) | DE60044350D1 (de) |
WO (1) | WO2000058470A1 (de) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998045420A1 (en) | 1997-04-10 | 1998-10-15 | Diagnocure Inc. | Pca3, pca3 genes, and methods of use |
US6828429B1 (en) | 1999-03-26 | 2004-12-07 | Henry M. Jackson Foundation For The Advancement Of Military Medicine | Prostate-specific gene, PCGEM1, and the methods of using PCGEM1 to detect, treat, and prevent prostate cancer |
ES2260059T3 (es) | 1999-09-29 | 2006-11-01 | Diagnocure Inc. | Rna mensajero del pca3 en tejidos benignos y malignos de prostata. |
AU2002241557A1 (en) * | 2000-11-01 | 2002-06-03 | Yongming Sun | Compositions and methods relating to prostate specific genes and proteins |
WO2002039431A2 (en) * | 2000-11-06 | 2002-05-16 | Diadexus, Inc. | Compositions and methods relating to prostate specific genes and proteins |
AU2002235164A1 (en) * | 2000-11-06 | 2002-05-21 | Diadexus, Inc. | Compositions and methods relating to prostate specific genes and proteins |
US20020150924A1 (en) * | 2000-11-21 | 2002-10-17 | Susana Salceda | Compositions and methods relating to prostate specific genes and proteins |
AU2002217991A1 (en) * | 2000-11-21 | 2002-06-03 | Diadexus, Inc. | Compositions and methods relating to prostate specific genes and proteins |
US20020155463A1 (en) * | 2000-12-01 | 2002-10-24 | Zairen Sun | Prostate polynucleotides and uses |
GB0119852D0 (en) | 2001-08-15 | 2001-10-10 | Univ York | Baculovirus |
US7816087B2 (en) | 2001-11-14 | 2010-10-19 | The United States Of America As Represented By The Department Of Health And Human Services | Gene expressed in prostate cancer and methods of use |
US20060188990A1 (en) * | 2002-04-19 | 2006-08-24 | Schering Aktiengesellschaft | Novel prostate tumor-specific promoter |
US20050282170A1 (en) | 2003-02-07 | 2005-12-22 | Diagnocure Inc. | Method to detect prostate cancer in a sample |
CA2491067A1 (en) | 2004-12-24 | 2006-06-24 | Stichting Katholieke Universiteit | Mrna rations in urinary sediments and/or urine as a prognostic marker for prostate cancer |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE69008521T2 (de) | 1989-03-07 | 1994-10-20 | Genentech Inc | Kovalente konjugate von lipiden und oligonukleotiden. |
ATE139255T1 (de) | 1989-10-24 | 1996-06-15 | Gilead Sciences Inc | Oligonukleotidanaloga mit neuartigen bindungen |
US5830686A (en) * | 1994-01-13 | 1998-11-03 | Calydon | Tissue-specific enhancer active in prostate |
JP2002510974A (ja) * | 1997-06-27 | 2002-04-09 | ヒューマン ジノーム サイエンシーズ,インコーポレイテッド | ヒトnk−3関連前立腺特異的遺伝子−1 |
-
2000
- 2000-03-24 WO PCT/US2000/007906 patent/WO2000058470A1/en active IP Right Grant
- 2000-03-24 AT AT00918373T patent/ATE466938T1/de not_active IP Right Cessation
- 2000-03-24 EP EP00918373A patent/EP1185639B1/de not_active Expired - Lifetime
- 2000-03-24 JP JP2000608751A patent/JP4942248B2/ja not_active Expired - Fee Related
- 2000-03-24 DE DE60044350T patent/DE60044350D1/de not_active Expired - Lifetime
- 2000-03-24 CA CA2368385A patent/CA2368385C/en not_active Expired - Fee Related
- 2000-03-24 AU AU39196/00A patent/AU778088B2/en not_active Ceased
Also Published As
Publication number | Publication date |
---|---|
JP4942248B2 (ja) | 2012-05-30 |
CA2368385A1 (en) | 2000-10-05 |
ATE466938T1 (de) | 2010-05-15 |
AU3919600A (en) | 2000-10-16 |
WO2000058470A1 (en) | 2000-10-05 |
EP1185639B1 (de) | 2010-05-05 |
EP1185639A1 (de) | 2002-03-13 |
AU778088B2 (en) | 2004-11-18 |
CA2368385C (en) | 2012-05-15 |
JP2003521236A (ja) | 2003-07-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE60044350D1 (de) | Prostata-spezifisches gen pcgem1 und methoden zu dessen verwendung zur erkennung, behandlung und prävention von prostatakrebs | |
WO2003004989A3 (en) | Compositions, kits, and methods for identification, assessment, prevention, and therapy of breast cancer | |
TW200728465A (en) | Compositions and methods for the therapy and diagnosis of prostate cancer | |
WO2003009814A3 (en) | Novel genes, compositions, kits, and methods for identification, assessment, prevention, and therapy of prostate cancer | |
EA200501772A1 (ru) | Способы измерения экспрессии генов из фиксированного и залитого в парафин образца ткани | |
DE60126592D1 (de) | Verfahren, zusammensetzungen und kits zur identifizierung und überwachung von brustkrebs | |
BR0213786A (pt) | Peptìdeos efetivos no tratamento de tumores e outras condições que requerem a remoção ou destruição de células | |
WO2001072962A3 (en) | Novel prostate-specific or testis-specific nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods | |
WO2004000094A3 (en) | Predictive markers in cancer therapy | |
ATE427771T1 (de) | Vorrichtung zur mehrstellenbehandlung von tachykardien | |
DE60020529D1 (de) | Antikörper zur krebsbehandlung und -diagnose | |
WO2001042467A3 (en) | Genes, compositions, kits, and methods for identification, assessment, prevention, and therapy of cervical cancer | |
WO2003000012A3 (en) | Compositions, kits, and methods for identification, assessment, prevention, and therapy of breast and ovarian cancer | |
WO2004106495A3 (en) | Compositions, kits, and methods for identification, assessment, prevention, and therapy of breast cancer | |
BR0209990A (pt) | Peptìdeos efetivos no tratamento de tumores e outras condições que requerem a remoção ou destruição de células | |
AU2003293141A8 (en) | Methods for identifying risk of breast cancer and treatments thereof | |
DE60045247D1 (de) | Zusammensetzungen und verfahren zur behandlung von tumoren | |
ATE287722T1 (de) | Mittel zur behandlung maligner erkrankungen unter verwendung des proteins yb-1 | |
DE69636041D1 (de) | Nachweis von brusttumorvirus-artigen sequenzen in brustkrebs bei menschen | |
DE60123138D1 (de) | Verwendung von progesteronrezeptorhemmern zur behandlung von steroid-resistentem brustkrebs | |
WO2003106648A3 (en) | COMPOSITIONS AND METHODS RELATED TO BREAST SPECIFIC GENES AND PROTEINS | |
WO2002042463A3 (en) | Compositions and methods relating to prostate specific genes and proteins | |
DK0950062T3 (da) | Proteinmarkörer for esophageal cancer | |
WO2002042776A3 (en) | Compositions and methods relating to prostate specific genes and proteins | |
WO2002039431A3 (en) | Compositions and methods relating to prostate specific genes and proteins |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition |